A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA
Year: 2004
Type: article
DOI: 10.3892/ijo.25.3.571
Authors: Tomohiro Emura, Norihiko Suzuki, Masahiro Yamaguchi, Hideyuki Ohshimo, Masakazu Fukushima
Institution: Taiho Pharmaceutical (Japan)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2025641756
